Calvenza®-03 EIV/EHV
Equine Rhinopneumonitis - Influenza Vaccine
-
CALVENZA®-03 EIV/EHV is an equine rhinopneumonitis and influenza, killed virus vaccine for healthy horses 6 months of age or older, including pregnant mares, against:
-
respiratory diseases due to equine herpesvirus types 1 and 4 (EHV-1 & EHV-4)
-
equine influenza virus (EIV) types A2 North American and A2 Eurasian
-
-
The first equine influenza vaccine updated to follow OIE guidelines to contain Florida sublineage clade 1
-
Flexible administration - intramuscular and intranasal with a pliable nasal applicator
Features
-
Incorporates Florida sublineage clade 1 (OH/03), Kentucky (KY/2/95), and Eurasian Newmarket/2/93 (NM/2/93) equine influenza strains
-
Unique EHV-1 equine respiratory origin isolate
-
Carbimmune® adjuvant formulation
-
Ultrafil® purification technology
-
Includes innovative pliable nasal applicator
-
Safe for use in foals as young as 6 months of age
-
Proven safe in pregnant mares
Benefits
-
Stimulates antibody production against EHV-1 & EHV-4
-
Carbimmune® adjuvant system allows a dual-phase antigen presentation to deliver both rapid and long-lasting immunity
-
Ultrafil® purification technology eliminates undesirable cellular components and extraneous protein to minimize the potential injection site reactions (such as heat, swelling, and inflammation)
-
Flexible dose administration using intramuscular or intranasal techniques
-
Pregnant mare may be safely vaccinated in any stage of gestation
-
Can initiate vaccination in foals as early as 6 months of age
Shake the bottle well before using. Using aseptic technique, inoculate horses intramuscularly (IM) with a 2mL dose.
Administer second 2mL dose IM in 3-4 weeks using a different injection site.
Administer a third 2mL dose in 3-4 weeks either by intramuscular or intranasal (IN) route.
The need for annual booster vaccinations has not been established for this product.; consultation with a veterinarian is recommended.
Precautions
-
Store at a temperature between 35° - 46°F (2° - 8°C)
-
Do not freeze
-
Do not vaccinate within 21 days of slaughter
-
Do not mix with other products
-
Use entire contents after opening
In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.
CALVENZA® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license. ULTRAFIL® and CARBIMMUNE® are registered trademarks of Boehringer Ingelheim Animal Health USA, Inc. ©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved